STOCK TITAN

TNL Mediagene regains Nasdaq Equity Rule compliance

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

TNL Mediagene regained compliance with Nasdaq’s Equity Rule, which requires a minimum of $2,500,000 in stockholders’ equity. Nasdaq said its determination followed review of the company’s October 30, 2026 Form 6-K concerning the completed sale of its Japanese operating subsidiaries, together with supplemental pro forma financial information.

A Mandatory Panel Monitor applies for 1 year from November 16, 2026. If Nasdaq staff finds the company again out of compliance during that period, staff will issue a Delist Determination Letter; the company may not submit a compliance plan, receive additional time, or be afforded an applicable cure period, but may request a new hearing.

Minimum stockholders’ equity $2,500,000 Nasdaq Equity Rule requirement
Mandatory Panel Monitor 1 year From the date of Nasdaq’s letter on November 16, 2026
Equity Rule regulatory
"regained compliance with the Equity Rule"
Mandatory Panel Monitor regulatory
"subject to a Mandatory Panel Monitor"
A mandatory panel monitor is an independent group tasked with regularly reviewing safety and key results during a clinical trial or regulated program to protect participants and ensure the study is conducted properly. For investors, this matters because the panel can recommend changes, pauses, or early stopping of a trial — actions that can speed up, delay, or quietly derail a program and therefore materially affect a company’s timeline and value, much like a referee whose calls change the outcome of a game.
Delist Determination Letter regulatory
"staff will issue a Delist Determination Letter"
A delist determination letter is a formal notice from a stock exchange telling a company it no longer meets listing rules and is facing removal from the exchange. For investors, it signals that the stock may lose its regular trading venue, which can sharply reduce liquidity and visibility—like being forced out of a busy shopping mall into a small flea market—raising the risk of price drops and harder-to-sell shares.
pro forma financial information financial
"supplemental pro forma financial information"
Pro forma financial information are adjusted financial numbers that show how a company’s results might look after a specific event or after removing one-time items, like a cleaned-up or “what if” version of its earnings. Investors use these figures to compare performance, judge future profitability, or evaluate the impact of mergers, restructurings or large transactions, but they require scrutiny because adjustments can make results look rosier than standard accounting statements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Nasdaq compliance did TNMG regain?

TNMG regained compliance with Nasdaq’s Equity Rule, which requires minimum stockholders’ equity of $2,500,000. Nasdaq made its determination after reviewing the company’s October 30, 2026 Form 6-K and supplemental pro forma financial information relating to the completed sale of its Japanese operating subsidiaries.

What happens if TNMG falls out of compliance during its Nasdaq monitor?

If Nasdaq staff finds TNMG again out of compliance with the Equity Rule during the monitor, staff will issue a Delist Determination Letter. TNMG may not submit a compliance plan, receive additional time, or be afforded an applicable cure period, but it may request a new hearing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16

OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2026

 

Commission File Number 001-42424

 

TNL Mediagene

 

4F., No. 88, Yanchang Rd.
Xinyi District
Taipei City 110
Taiwan
+886-2-6638-5108

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

 

 

 

 

Explanatory Note

 

As previously reported on a Form 6-K furnished to the U.S. Securities and Exchange Commission on August 25, 2026, TNL Mediagene, a Cayman Islands company (the “Company”), received a letter from the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) dated August 23, 2026, notifying that the Company’s request for continued listing on The Nasdaq Capital Market has been granted, subject to the Company’s satisfaction of certain conditions, including demonstrating compliance with the Listing Rule 5550(b)(1) (the “Equity Rule”) on or before October 30, 2026.

 

On November 16, 2026, the Company received a letter (the “Letter”) from Nasdaq, confirming that the Company regained compliance with the Equity Rule, and is in full compliance with the terms set forth in the Panel’s decision letter dated August 23, 2026.

 

In addition, pursuant to the Listing Rule 5815(d)(4)(B), the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the Letter. If within that one-year monitoring period, the Listing Qualifications Department (the “Staff”) finds the Company again out of compliance with the Equity Rule, then, notwithstanding the Listing Rule 5810(c)(2), the Company will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency, and the Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, nor will the Company be afforded an applicable cure or compliance period pursuant to the Listing Rule 5810(c)(3). Instead, the Staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing with the initial Panel or a newly convened Hearings Panel if the initial Panel is unavailable, as provided by the Listing Rule 5815(d)(4)(C).

 

A copy of the press release regarding the Letter confirming that the Company regained compliance and notifying that the Company is subject to a Mandatory Panel Monitor for a period of one year from the date of the Letter is furnished herewith as Exhibit 99.1 to this Report on Form 6-K and is incorporated by reference herein.

 

Exhibit No.   Description of Exhibits
99.1   Press Release by TNL Mediagene dated November 18, 2026

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  TNL Mediagene
     
Date: November 18, 2026 By: /s/ Tae Jun Park
    Name:  Tae Jun Park
    Title: General Counsel and
Chief Corporate Affairs Officer

 

2

 

Exhibit 99.1

 

TNL Mediagene Regains Compliance with Nasdaq’s Equity Rule

 

TAIPEI, TAIWAN, November 18, 2026 -- TNL Mediagene (Nasdaq: TNMG) (the “Company”), a technology and digital media company providing AI-driven advertising, marketing technology, content commerce and data analytics solutions, and operating multi-language digital media brands across Asia, today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) on November 16, 2026, confirming that the Company has regained compliance with Listing Rule 5550(b)(1) (the “Equity Rule”), as required by the Nasdaq Hearings Panel’s (the “Panel”) decision dated August 23, 2026.

 

The Nasdaq staff made this determination of compliance following its review of the Company’s Report on Form 6-K furnished on October 30, 2026 in connection with the completion of the sale of the Company’s Japanese operating subsidiaries, together with supplemental pro forma financial information provided by the Company. Accordingly, the Company has regained compliance with the Equity Rule, which requires a minimum stockholders’ equity of $2,500,000, and has satisfied the terms of the Panel’s decision.

 

Pursuant to Listing Rule 5815(d)(4)(B), the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of Nasdaq’s letter. If, within that one-year monitoring period, the Listing Qualifications Department finds the Company again out of compliance with the Equity Rule, then, notwithstanding Rule 5810(c)(2), the Company will not be permitted to provide the Listing Qualifications Department with a plan of compliance with respect to that deficiency, and the Listing Qualifications Department will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, nor will the Company be afforded an applicable cure or compliance period pursuant to Rule 5810(c)(3). Instead, the Nasdaq staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing with the initial Panel or a newly convened Hearings Panel if the initial Panel is unavailable, as provided by Listing Rule 5815(d)(4)(C).

 

About TNL Mediagene

 

Headquartered in Taipei, TNL Mediagene (Nasdaq: TNMG) is a technology and digital media company providing AI-driven advertising, marketing technology, content commerce, and data analytics solutions to brands and agencies across Asia. The Company combines advertising and marketing technology platforms with a portfolio of established digital media brands to deliver integrated solutions for the evolving digital landscape.

 

The Company’s technology offerings include AI-driven advertising, marketing and digital studio services, content commerce, and advanced data analytics capabilities. These solutions are supported by the Company’s well-established multi-language digital media brands in Chinese and English, spanning business, technology, lifestyle, and culture, which provide audience engagement and first-party data.

 

Known for its appeal to younger audiences and high-quality content, TNL Mediagene has approximately 230 employees with offices in Taiwan.

 

https://www.tnlmediagene.com/

 

For further information, please contact:

Media: PR@tnlmediagene.com

Investors: IR@tnlmediagene.com 

 

 

 

Cautionary Statement Regarding Forward-Looking Statements 

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene’s future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “aim,” “seek” or the negative or plural forms of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements.

 

These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication speak only as of the date they are made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene’s filings with the Securities and Exchange Commission, including the risks and uncertainties set forth under the heading “Risk Factors” in TNL Mediagene’s Annual Report on Form 20-F filed on April 30, 2026, as may be supplemented or amended by TNL Mediagene’s Reports of a Foreign Private Issuer on Form 6-K. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

 

Important factors include, among others, TNL Mediagene’s ability to maintain compliance with Nasdaq’s continued listing requirements, including the stockholders’ equity and minimum bid price requirements, during the one-year Mandatory Panel Monitor period and thereafter; the potential delisting of TNL Mediagene’s securities from Nasdaq, without the benefit of a compliance plan or cure period, if TNL Mediagene fails to maintain compliance with the stockholders’ equity requirement during the monitoring period; and other risks described in TNL Mediagene’s filings with the Securities and Exchange Commission.

 

TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are material that could also cause actual results to differ from those contained in the forward-looking statements.

 

In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.

 

 

Filing Exhibits & Attachments

1 document

Keep reading